Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression

scientific article published on 01 August 2002

Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1034/J.1399-0039.2002.600204.X
P698PubMed publication ID12392508

P2093author name stringL J Abraham
E J Croager
L C Goldie-Cregan
P2860cites workCD30 ligand is expressed on resting normal and malignant human B lymphocytesQ71127530
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosisQ72348191
High serum level of soluble CD30 in acute primary HIV-1 infectionQ73353186
The Sequence of the Human GenomeQ22065842
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNFQ24316162
Effective amplification of long targets from cloned inserts and human genomic DNAQ24562806
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence dataQ29547902
TRANSFAC: an integrated system for gene expression regulationQ29614502
Analysis of expressed sequence tags indicates 35,000 human genesQ33903985
PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templatesQ35100239
CD30, Th2 cytokines and HIV infection: a complex and fascinating linkQ40611296
Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.Q40870263
Cross-linking of CD30 induces HIV expression in chronically infected T cellsQ41342620
CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infectionQ41779853
Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).Q44348615
Characterisation of the human CD30 ligand gene structureQ48040598
Gene index analysis of the human genome estimates approximately 120,000 genes.Q52077979
Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient MiceQ57185434
Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsQ59090441
Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the diseaseQ61733744
High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed jointsQ70823380
CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated conditionQ71047892
P433issue2
P304page(s)139-146
P577publication date2002-08-01
P1433published inTissue AntigensQ1573131
P1476titleCharacterization of the murine CD30 ligand (CD153) gene: gene structure and expression
P478volume60

Reverse relations

cites work (P2860)
Q58801536Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
Q95326370The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice